SCHEMBL8473603

SCHEMBL8473603

CCCn1c(C)nc2c(NO)cccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.44
MAPK1 P28482 5/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
ALOX15 P16050 4/20 0.41
MAPT P10636 4/20 0.41
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 2/20 0.41
LMNA P02545 2/20 0.41
USP2 O75604 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HTT P42858 3/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8475456 0.88 CYP1A2 (0.43) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8466050 0.80 CYP1A2 (0.60) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL9847098 0.80 TLR8 (0.57) CYP3A4MAPK1CYP1A2CYP2D6CYP2C9
SCHEMBL6126621 0.77 TLR8 (0.60) CYP3A4MAPK1SMN1; SMN2ALOX15MAPT
Hydrochloric Acid SCHEMBL6117482 0.76 TLR8 (0.58) CYP3A4MAPK1SMN1; SMN2ALOX15MAPT
SCHEMBL7568916 0.75 CNR2 (0.46) CYP3A4MAPK1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL7485320 0.75 NPSR1 (0.44) MAPK1CYP1A2CYP2C19SMN1; SMN2MAPT
SCHEMBL6118179 0.71 DCTPP1 (0.61) MAPTTDP1LMNAHTTALDH1A1
SCHEMBL8016313 0.71 TLR8 (0.67) SMN1; SMN2TSHRLMNAHTTKDM4E
SCHEMBL229041 0.69 POLB (0.67) SMN1; SMN2ALOX15MAPTTDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012068211-A1 TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-05-24 WO disclosed